Patents by Inventor Yannick Quesnel

Yannick Quesnel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUNDS AS SELF-TANNING SUBSTANCES AND TANNING COMPOSITIONS THEREOF
    Publication number: 20240058240
    Abstract: A self-tanning composition, such as a sunless tanning composition, a moisturizing composition, or a haircare composition, includes a self-tanning substance. The composition can result in increasing the amount of melanin in melanocytes, increasing melanin synthesis, improving melanin transport, and/or improving the distribution of melanin in suprabasal layers. The composition can be used in methods for darkening skin and/or for sunless tanning.
    Type: Application
    Filed: June 25, 2021
    Publication date: February 22, 2024
    Inventors: Sandra HUYSSEUNE, Alex VEITHEN, Yannick QUESNEL
  • Olfactory receptor involved in the perception of musk fragrance and the use thereof
    Patent number: 11867685
    Abstract: The invention relates to the identification of OR5A2 as an Olfactory Receptor that binds natural musk and synthetic musks. The invention encompasses the use of the interaction of OR5A2 polypeptides and nitromusk, polycyclic musk, macrocyclic musk and alicyclic musks as the basis of screening assays for agents that specifically modulate the activity of the OR of the invention.
    Type: Grant
    Filed: December 5, 2018
    Date of Patent: January 9, 2024
    Assignee: CHEMCOM S.A.
    Inventors: Sandra Huysseune, Alex Veithen, Yannick Quesnel
  • COMPOUNDS REDUCING MALODOUR PERCEPTION AND THE USE THEREOF
    Publication number: 20220378675
    Abstract: The present invention relates to new malodour-counteracting agents of formula (I) or stereoisomers thereof, particularly useful in blocking the olfactory perception of androstenone, Formula (I), wherein R1, R2, R3, R4, R5, R6, R7 and X have the same meaning as that defined in the claims. The present invention also relates to consumer products comprising said agents. The present invention also relates to the use of said agents to suppress or attenuate undesirable odour, as well as to methods to suppress or attenuate undesirable odour employing said compounds.
    Type: Application
    Filed: June 1, 2022
    Publication date: December 1, 2022
    Applicants: CHEMCOM S.A., GIVAUDAN S.A.
    Inventors: Pierre Chatelain, Markus Gautschi, Thierry Granier, Yannick Quesnel, Charles Stanley Sell, Alex Veithen
  • Compounds reducing malodour perception and the use thereof
    Patent number: 11382848
    Abstract: The present invention relates to new malodour-counteracting agents of formula (I) or stereoisomers thereof, particularly useful in blocking the olfactory perception of androstenone, Formula (I), wherein R1, R2, R3, R4, R5, R6, R7 and X have the same meaning as that defined in the claims. The present invention also relates to consumer products comprising said agents. The present invention also relates to the use of said agents to suppress or attenuate undesirable odour, as well as to methods to suppress or attenuate undesirable odour employing said compounds.
    Type: Grant
    Filed: January 30, 2018
    Date of Patent: July 12, 2022
    Assignees: CHEMCOM S.A., GIVAUDAN S.A.
    Inventors: Pierre Chatelain, Markus Gautschi, Thierry Granier, Yannick Quesnel, Charles Stanley Sell, Alex Veithen
  • MALODOR COUNTERACTING COMPOSITION AND AGENT AND THE USE THEREOF
    Publication number: 20220125983
    Abstract: A malodor counteracting composition has nefopam, or a polymorph, a hydrate or a solvate thereof. The malodor counteracting composition is useful as an attenuator or suppressor for attenuating or suppressing malodors, such as earthy malodor, musty malodor, and/or moldy malodor caused by malodor causing agents, such as geosmin and 2-methylisoborneol.
    Type: Application
    Filed: May 6, 2019
    Publication date: April 28, 2022
    Inventors: Alex VEITHEN, Pierre CHATELAIN, Yannick QUESNEL
  • 1-imidazothiadiazolo-2H-pyrrol-5-one derivatives
    Patent number: 11286266
    Abstract: The present invention relates to 1-imidazothiadiazolo-2H-pyrrol-5-one derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
    Type: Grant
    Filed: May 6, 2019
    Date of Patent: March 29, 2022
    Inventors: Hugues Chanteux, Yannick Quesnel, Claude Delatour, Laurent Provins
  • 2-oxo-1,3-oxazolidinyl imidazothiadiazole derivatives
    Patent number: 11155565
    Abstract: The present invention relates to 2-oxo-1,3-oxazolidinyl imidazothiadiazole derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
    Type: Grant
    Filed: July 5, 2018
    Date of Patent: October 26, 2021
    Inventors: Laurent Provins, Hugues Chanteux, Yannick Quesnel
  • OLFACTORY RECEPTOR INVOLVED IN THE PERCEPTION OF MUSK FRAGRANCE AND THE USE THEREOF
    Publication number: 20210164967
    Abstract: The invention relates to the identification of OR5A2 as an Olfactory Receptor that binds natural musk and synthetic musks. The invention encompasses the use of the interaction of OR5A2 polypeptides and nitromusk, polycyclic musk, macrocyclic musk and alicyclic musks as the basis of screening assays for agents that specifically modulate the activity of the OR of the invention.
    Type: Application
    Filed: December 5, 2018
    Publication date: June 3, 2021
    Inventors: Sandra HUYSSEUNE, Alex VEITHEN, Yannick QUESNEL
  • 1-IMIDAZOTHIADIAZOLO-2H-PYRROL-5-ONE DERIVATIVES
    Publication number: 20210107922
    Abstract: The present invention relates to 1-imidazothiadiazolo-2H-pyrrol-5-one derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
    Type: Application
    Filed: May 6, 2019
    Publication date: April 15, 2021
    Inventors: Hugues Chanteux, Yannick Quesnel, Claude Delatour, Laurent Provins
  • 2-OXO-1,3-OXAZOLIDINYL IMIDAZOTHIADIAZOLE DERIVATIVES
    Publication number: 20200231599
    Abstract: The present invention relates to 2-oxo-1,3-oxazolidinyl imidazothiadiazole derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
    Type: Application
    Filed: July 5, 2018
    Publication date: July 23, 2020
    Inventors: Laurent PROVINS, Hugues CHANTEUX, Yannick QUESNEL
  • COMPOUNDS REDUCING MALODOUR PERCEPTION AND THE USE THEREOF
    Publication number: 20190374451
    Abstract: The present invention relates to new malodour-counteracting agents of formula (I) or stereoisomers thereof, particularly useful in blocking the olfactory perception of androstenone, Formula (I), wherein R1, R2, R3, R4, R5, R6, R7 and X have the same meaning as that defined in the claims. The present invention also relates to consumer products comprising said agents. The present invention also relates to the use of said agents to suppress or attenuate undesirable odour, as well as to methods to suppress or attenuate undesirable odour employing said compounds.
    Type: Application
    Filed: January 30, 2018
    Publication date: December 12, 2019
    Applicants: CHEMCOM S.A., GIVAUDAN S.A.
    Inventors: Pierre Chatelain, Markus Gautschi, Thierry Granier, Yannick Quesnel, Charles Stanley Sell, Alex Veithen
  • 2-oxo-1-imidazolidinyl imidazothiadiazole derivatives
    Patent number: 8957218
    Abstract: The present invention relates to 2-oxo-1-imidazolidinyl imidazothiadiazole derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
    Type: Grant
    Filed: April 17, 2012
    Date of Patent: February 17, 2015
    Assignee: UCB Pharma S.A.
    Inventors: Laurent Provins, Yannick Quesnel
  • 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
    Patent number: 8957226
    Abstract: The present invention relates to optically enriched or substantially optically pure 4-substituted-pyrrolidin-2-ones of formula (III), and their uses for the synthesis of 2-oxo-pyrrolidin-1-yl derivatives.
    Type: Grant
    Filed: September 12, 2006
    Date of Patent: February 17, 2015
    Assignee: UCB Pharma S.A.
    Inventors: Celal Ates, Francoise Lurquin, Yannick Quesnel, Arnaud Schule
  • 2-oxo-1-pyrrolidinyl imidazothiadiazole derivatives
    Patent number: 8822508
    Abstract: The present invention relates to 2-oxo-1-pyrrolidine imidazothiadiazole derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
    Type: Grant
    Filed: October 21, 2010
    Date of Patent: September 2, 2014
    Assignee: UCB Pharma, S.A.
    Inventors: Yannick Quesnel, Laurent Turet, Joël Mercier
  • 2-Oxo-1-Imidazolidinyl Imidazothiadiazole Derivatives
    Publication number: 20140148489
    Abstract: The present invention relates to 2-oxo-1-imidazolidinyl imidazothiadiazole derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
    Type: Application
    Filed: April 17, 2012
    Publication date: May 29, 2014
    Applicant: UCB PHARMA, S.A.
    Inventors: Laurent Provins, Yannick Quesnel
  • 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
    Patent number: 8586623
    Abstract: The present invention concerns 2-oxo-1-pyrrolidine derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
    Type: Grant
    Filed: April 6, 2012
    Date of Patent: November 19, 2013
    Assignee: UCB Pharma, S.A.
    Inventors: Benoit Kenda, Yannick Quesnel, Ali Ates, Philippe Michel, Laurent Turet, Joel Mercier
  • 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
    Patent number: 8518943
    Abstract: The present invention concerns 2-oxo-1-pyrrolidine derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
    Type: Grant
    Filed: April 6, 2012
    Date of Patent: August 27, 2013
    Assignee: UCB Pharma, S.A.
    Inventors: Benoit Kenda, Yannick Quesnel, Ali Ates, Philippe Michel, Laurent Turet, Joel Mercier
  • 2-Oxo-1-Pyrrolidinyl Imidazothiadiazole Derivatives
    Publication number: 20120245208
    Abstract: The present invention relates to 2-oxo-1-pyrrolidine imidazothiadiazole derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
    Type: Application
    Filed: October 21, 2010
    Publication date: September 27, 2012
    Applicant: UCB PHARMA, S.A.
    Inventors: Yannick Quesnel, Laurent Turet, Joël Mercier
  • 2-Oxo-1-Pyrrolidine Derivatives, Processes for Preparing Them and Their Uses
    Publication number: 20120214815
    Abstract: The present invention concerns 2-oxo-1-pyrrolidine derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
    Type: Application
    Filed: April 6, 2012
    Publication date: August 23, 2012
    Applicant: UCB Pharma, S.A.
    Inventors: Benoît KENDA, Yannick QUESNEL, Ali ATES, Philippe MICHEL, Laurent TURET, Joël MERCIER
  • 2-Oxo-1-Pyrrolidine Derivatives, Processes for Preparing Them and Their Uses
    Publication number: 20120196866
    Abstract: The present invention concerns 2-oxo-1-pyrrolidine derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
    Type: Application
    Filed: April 6, 2012
    Publication date: August 2, 2012
    Applicant: UCB PHARMA, S.A.
    Inventors: Benoît Kenda, Yannick Quesnel, Ali Ates, Philippe Michel, Laurent Turet, Joël Mercier